查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611034

食物過敏治療市場規模、佔有率、趨勢分析報告：按過敏原類型、按藥物類型、按給藥途徑、按最終用途、按地區、細分市場預測，2025-2030 年

Food Allergy Treatment Market Size, Share & Trends Analysis Report By Allergen Type, By Drug Type, By Route of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

食物過敏治療市場成長與趨勢

Grand View Research, Inc.最新報告顯示，到2030年，全球食物過敏治療市場規模預計將達到113.3億美元，預計2025年至2030年複合年成長率為8.27%。推動市場成長的關鍵因素包括全球食物過敏盛行率的上升以及新藥研發活動的活性化。此外，採用新的生物藥品來治療食物過敏以及尋求食物過敏治療的患者就診次數的增加可能會推動預測期內的市場成長。

過敏治療資金的增加正在促進創新治療方法的研究和開發並增加可用性，滿足對更有效的治療方法和管理策略不斷成長的需求。財政支持的增加正在推動市場成長，並刺激為受這種情況影響的人們開發更安全、更容易獲得的解決方案。 2022年9月，臨床階段生技公司COUR Pharmaceuticals完成了由Alpha Wave Ventures領投的3,000萬美元資金籌措。這筆資金籌措將支持 COUR 創新免疫修飾奈米顆粒（COUR NanoParticles 或 CNP）技術平台的擴展。此外，兩項針對食物過敏治療的概念驗證測試也將取得進展。這項重要的投資凸顯了推進免疫系統重編程方法來解決自體免疫疾病和食物過敏的潛力。

Xolair 和 PALFORZIA 等新藥將支持市場成長。 2020年1月，FDA核准PALFORZIA標誌著食物過敏治療的一個重要里程碑。 PALFORZIA 透過提供花生過敏的治療選擇來解決未滿足的關鍵醫療需求。在核准之前，患者除了嚴格避免外，別無選擇，但這項核准引入了一個可能改變生活的解決方案。這種口服免疫療法產品專門用於減少過敏反應，包括過敏反應，這種過敏反應可能因 4 至 17 歲確診花生過敏的兒童意外接觸花生而發生。 FDA 的風險評估和緩解策略 (REMS) 要求確保 PALFORZIA 的安全和受控管理，以提高病患安全和醫療保健提供者的信心。 PALFORZIA 與避免花生的飲食結合使用，並根據患者的需要進行調整，而在氣喘不受控制的情況下，嗜伊紅性食道炎和其他嗜酸性粒細胞胃腸道疾病是禁忌的，這進一步強調了其對特定患者族群的安全性和適用性。

然而，雀巢的 Palforzia 面臨重大挑戰。儘管其研發花費了 26 億美元，但這種治療方法對許多潛在患者來說還是很麻煩。當 Palforzia 於 2020 年上市時，醫生最初很高興向患者提供該藥物。然而，COVID-19 大流行打亂了面對面治療計劃。因此，醫生決定向大約 1,000 名患者介紹這種新藥，作為疫情後的選擇。令人驚訝的是，只有六人表示對這種治療感興趣，這種治療被譽為治療危及生命的花生過敏的有效解決方案，並已獲得美國當局的批准。即使多年後，許多醫生仍然不開立 Palforzia 處方。在美國各地，醫生和患者似乎都選擇傳統方法來避免過敏原並攜帶腎上腺素注射劑以備不時之需。在一項重大的市場開發中，雀巢於 2023 年 9 月將其 Palforzia 業務出售給過度診斷和治療專家 Stallergenes Greer。這項策略性舉措是繼雀巢先前宣布對 Palforzia 進行全面改革之後，作為協議的一部分，雀巢將獲得里程碑付款和持續的特許權使用費。

食物過敏治療市場報告亮點

  • 按過敏原類型分類，花生細分市場處於領先地位，到 2024 年，其銷售佔有率最高可達 20.55%。推動市場成長的關鍵因素包括全球花生過敏盛行率的上升以及新藥研發活動的活性化。此外，擴大採用新的生物藥品來治療過敏，以及增加尋求治療這種過敏的患者就診次數，預計也將在預測期內推動市場成長。
  • 按藥物類型分類，腎上腺素細分市場在 2024 年以 41.0% 的最大銷售佔有率引領市場。腎上腺素被認為是治療過敏症狀的首選藥物。這是因為它被用作緊急過敏症狀的初始治療。
  • 從給藥途徑來看，口服給藥預計在預測期內將以穩定的複合年成長率成長。口服食物過敏治療主要採用口服免疫療法（OIT），其中包括逐漸攝取受控劑量的食物過敏原。
  • 按最終用途分類，醫院藥房細分市場佔據最大收益佔有率，2024 年將達到 55.48%。醫院藥局是重要的分銷管道，有助於提供和有效分配基本藥物和治療方法，以管理醫院內的食物過敏。
  • 北美地區在 2024 年以 39.14% 的收益佔有率佔據市場主導地位。由於人們越來越了解過敏治療的巨大潛力，該地區佔據了主要的市場佔有率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章食物過敏治療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 食物過敏治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析

第4章食物過敏治療市場：依過敏原類型估計與趨勢分析

  • 細分儀表板
  • 全球食物過敏治療市場過敏原類型波動分析
  • 2018-2030年全球食物過敏治療市場規模及趨勢分析（依過敏原型態）
  • 乳製品
  • 家禽產品
  • 堅果
  • 花生
  • 貝類
  • 小麥
  • 大豆
  • 其他

第5章食物過敏治療市場：依藥物類型估算與趨勢分析

  • 細分儀表板
  • 全球食物過敏治療市場藥物種類波動分析
  • 2018-2030年全球食物過敏治療市場規模及趨勢分析（依藥物類型）
  • 抗組織胺藥
  • 腎上腺素
  • 免疫療法
    • 索萊爾
    • 帕爾福齊亞
    • 其他

第6章食物過敏治療市場：依給藥途徑估計與趨勢分析

  • 細分儀表板
  • 全球食物過敏治療市場波動分析
  • 2018-2030年全球食物過敏治療市場規模與趨勢分析（依給藥途徑）
  • 腸外給藥
  • 口服給藥
  • 其他

第7章食物過敏治療市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 全球食物過敏治療市場波動分析
  • 2018-2030 年全球食物過敏治療市場規模與趨勢分析（依最終用途）
  • 醫院藥房
  • 零售藥房
  • 其他

第8章食物過敏治療市場：按地區估計和趨勢分析

  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 2024年主要企業市場佔有率分析
    • Sanofi SA
    • Stallergenes Greer
    • DBV Technologies
    • Vedanta Biosciences, Inc.
    • Alladapt Immunotherapeutics, Inc.
    • COUR Pharmaceuticals
    • Aravax
    • Prota Therapeutics Pty Ltd
    • Teva Pharmaceuticals Industries Ltd.
    • F. Hoffman-La Roche Ltd.
    • Novartis AG

第10章結論

Product Code: GVR-4-68040-290-8

Food Allergy Treatment Market Growth & Trends:

The global food allergy treatment market size is anticipated to reach USD 11.33 billion by 2030 and is projected to grow at a CAGR of 8.27% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key factors propelling the market growth includes the rising prevalence of food allergies worldwide and increasing R&D activities for novel drugs. Moreover, the adoption of new biological agents to treat food allergies and an increase in clinic visits by patients seeking therapy for food allergies are likely to drive the market growth over the forecast period.

The increase in funding for allergy treatments is driving advancements in research, development, and accessibility of innovative therapies, addressing the growing demand for more effective treatments & management strategies. This heightened financial support is propelling market growth and fueling the development of safer and more accessible solutions for those affected by this condition. In September 2022, COUR Pharmaceuticals, a clinical-stage biotechnology company, completed a USD 30 million financing round, with Alpha Wave Ventures as the lead investor. This funding will support the expansion of COUR's innovative immune-modifying nanoparticles (COUR NanoParticles or CNPs) technology platform. Furthermore, it will facilitate the progression of the company's two human proof-of-concept studies focused on treating food allergies. This significant investment highlights the potential for advancing immune system reprogramming approaches to address autoimmune disorders and food allergies.

Novel drugs such as Xolair, and PALFORZIA boost the market growth. In January 2020, the FDA's approval of PALFORZIA marked a significant milestone in Food Allergy Treatment. PALFORZIA addresses a crucial unmet medical need by providing a treatment option for peanut allergies. Prior to its approval, patients had limited choices beyond strict avoidance, and this approval introduced a potentially life-changing solution. This oral immunotherapy product is specifically indicated for mitigating allergic reactions, including anaphylaxis that might occur from accidental peanut exposure in children aged 4 to 17 years with a confirmed diagnosis of peanut allergy. The FDA's requirement for a Risk Evaluation and Mitigation Strategy (REMS) ensures the safe and controlled administration of PALFORZIA, boosting patient safety and healthcare provider confidence. PALFORZIA, used alongside a peanut-avoidant diet, is tailored to meet the needs of patients while being contraindicated in cases of uncontrolled asthma and eosinophilic esophagitis and other eosinophilic gastrointestinal diseases, further emphasizing its safety and suitability for specific patient populations.

However, Nestle's Palforzia faced significant challenges. Despite a substantial investment of USD 2.6 billion in its development, the treatment regimen proved to be too cumbersome for many potential patients. When Palforzia entered the market in 2020, physicians were initially excited to offer it to their patients. However, the COVID-19 pandemic disrupted in-person treatment plans. As a result, doctors resorted to informing approximately 1,000 patients about the new drug as an option for postpandemic use. Surprisingly, only six individuals expressed interest in the treatment that had been heralded as an efficient solution for life-threatening peanut allergy, having received clearance from U.S. authorities. Even after three years, many physicians have not prescribed Palforzia. Across the U.S., it appears that doctors & patients are opting for the traditional approach of avoiding allergens and carrying adrenaline injections for emergencies instead. As a significant development in the market, in September 2023, Nestle divested its Palforzia business to Stallergenes Greer, a company specifying in allergy diagnosis and treatment. This strategic move followed Nestle's earlier announcement of a review of Palforzia, with Nestle set to receive milestone payments and ongoing royalties as part of the agreement.

Food Allergy Treatment Market Report Highlights:

  • By allergen type, the peanuts segment led the market with the largest revenue share of 20.55% in 2024. Key factors propelling market growth include, rising prevalence of peanut allergies worldwide and increasing R&D activities for novel drugs. Moreover, growing adoption of new biological agents to treat allergies and an increase in clinic visits by patients seeking therapy for this allergy are likely to drive the market growth over the forecast period
  • Based on drug type, the epinephrine segment led the market with the largest revenue share of 41.0% in 2024. Epinephrine is considered to be the medication of choice for treatment of allergic conditions. Owing to its use as the initial treatment of choice for emergency allergic conditions
  • By route of administration, the oral segment is projected to grow at a steady CAGR over the forecast period. Oral food allergy treatment primarily employs Oral Immunotherapy (OIT), involving the gradual consumption of controlled amounts of food allergen
  • By end use, the hospital pharmacies segment held the market with the largest revenue share of 55.48% in 2024. Hospital pharmacies serve as a critical distribution channel, facilitating the availability and efficient dispensation of medications and treatments essential for managing food allergies within a hospital environment
  • North America dominated the market with the revenue share of 39.14% in 2024. The region held a major market share due to an increase in understanding of the high potential associated with allergy drugs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Type
    • 1.2.2. Allergen Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Food Allergy Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of peanut allergy
      • 3.2.1.2. Increasing funding for novel drug discovery
      • 3.2.1.3. Rising awareness programs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment and products
  • 3.3. Food Allergy Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Food Allergy Treatment Market: Allergen Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Food Allergy Treatment Market by Allergen Type Outlook
  • 4.3. Global Food Allergy Treatment Market Size & Trend Analysis, by Allergen Type, 2018 to 2030 (USD Million)
  • 4.4. Dairy Products
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Poultry Product
    • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Tree Nuts
    • 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Peanuts
    • 4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Shellfish
    • 4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Wheat
    • 4.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Wheat
    • 4.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Soys
    • 4.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. Other
    • 4.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Food Allergy Treatment Market: Drug Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Food Allergy Treatment Market Drug Type Movement Analysis
  • 5.3. Global Food Allergy Treatment Market Size & Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
  • 5.4. Antihistamines
    • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Epinephrine
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Immunotherapy
    • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.6.2. Xolair
      • 5.6.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.6.3. PALFORZIA
      • 5.6.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.6.4. Others
      • 5.6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Food Allergy Treatment Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Food Allergy Treatment Market Movement Analysis
  • 6.3. Global Food Allergy Treatment Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Parenteral Route
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Oral Route
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Other
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Food Allergy Treatment Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Food Allergy Treatment Market Movement Analysis
  • 7.3. Global Food Allergy Treatment Market Size & Trend Analysis, by End Use 2018 to 2030 (USD Million)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Retail Pharmacies
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Food Allergy Treatment Market: Regional Estimates & Trend Analysis by

  • 8.1. Regional Market Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Sanofi SA
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Stallergenes Greer
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. DBV Technologies
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Vedanta Biosciences, Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Alladapt Immunotherapeutics, Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. COUR Pharmaceuticals
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Aravax
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Prota Therapeutics Pty Ltd
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Teva Pharmaceuticals Industries Ltd.
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. F. Hoffman-La Roche Ltd.
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Novartis AG
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives

Chapter 10. Conclusion

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 5 North America Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 6 North America Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 7 North America Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 11 U.S. Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Canada Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Canada Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 17 Mexico Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 19 Mexico Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Europe Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Germany Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 Germany Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 UK Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 30 UK Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 31 UK Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 32 UK Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 France Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 34 France Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 35 France Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 France Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Italy Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million
  • Table 40 Italy Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Spain Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 Sapin Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Denmark Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 46 Denmark Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 48 Denmark Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Sweden Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 50 Sweden Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 Sweden Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Norway Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 54 Norway Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Norway Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Japan Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 63 Japan Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Japan Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 China Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 67 China Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 68 China Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 69 China Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 India Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 71 India Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 72 India Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 73 India Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Australia Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 75 Australia Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 76 Australia Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 Australia Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 78 South Korea Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 79 South Korea Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 81 South Korea Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Thailand Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 83 Thailand Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 Thailand Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Latin America Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 88 Latin America Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million
  • Table 90 Latin America Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 Brazil Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 92 Brazil Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 Brazil Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 95 Argentina Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 96 Argentina Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 98 Argentina Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 99 MEA Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 100 MEA Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 101 MEA Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 102 MEA Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 103 MEA Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104 South Africa Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 105 South Africa Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 107 South Africa Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 UAE Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 113 UAE Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 115 UAE Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Food Allergy Treatment Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Food Allergy Treatment Market snapshot (2023)
  • Fig. 9 Food Allergy Treatment Market: Segment snapshot (2023)
  • Fig. 10 Competitive Insights (2023)
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Food Allergy Treatment Market driver impact
  • Fig. 15 Food Allergy Treatment Market restraint impact
  • Fig. 16 Porter's Five Forces Analysis
  • Fig. 17 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 18 Strategic alliance analysis
  • Fig. 19 Recent developments & impact analysis, by key market participants
  • Fig. 20 Key company market share analysis, 2024
  • Fig. 21 Company market position analysis
  • Fig. 22 Definition and scope, by Allergen Type
  • Fig. 23 Allergen Type market share analysis, 2024 & 2030
  • Fig. 24 Global Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Fig. 25 Dairy Products market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 26 Poultry Product market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 27 Tree Nuts market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 28 Peanuts market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 29 Shellfish market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 30 Wheat market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 31 Soys market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 32 Other market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 33 Definition and scope, by drug type
  • Fig. 34 Drug type market share analysis, 2024 & 2030
  • Fig. 35 Global Food Allergy Treatment Market, by drug type, 2018 - 2030 (USD Million)
  • Fig. 36 Antihistamines market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 37 Epinephrine market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 38 Immunotherapy market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 39 Xolair market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 40 PALFORZIA NSAIDs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 41 Other immunotherapies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 42 Definition and scope, by Route of Administration
  • Fig. 43 Route of Administration market share analysis, 2024 & 2030
  • Fig. 44 Global Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Fig. 45 Parenteral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 46 Oral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 47 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 48 Definition and scope, by End Use
  • Fig. 49 End Use market share analysis, 2024 & 2030
  • Fig. 50 Segment dashboard
  • Fig. 51 Global Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Fig. 52 Hospital Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 53 Retail Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 54 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 55 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 56 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 57 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 58 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 59 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 60 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 61 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 62 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 63 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 64 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 65 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 66 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 67 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 68 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 69 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 70 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 71 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 72 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 73 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 74 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 75 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 76 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 77 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
  • Fig. 78 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 79 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 80 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 81 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 82 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)